세계의 의약품 첨가제 시장 (~2028년) : 제품별 (유기 (유기 화학, 탄수 화물), 무기 (탄산 칼슘)), 기능별 (충전제, 결합제, 윤활제, 희석제), 제형별 (경구제, 비경구제), 용도별 (안정제)

■ 영문 제목 : Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 PH3047-24 입니다.■ 상품코드 : PH3047-24
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2023년 12월
■ 페이지수 : 504
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : Email (주문후 24시간내 납품)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD4,950 ⇒환산￦6,682,500견적의뢰/주문/질문
Multi User (Five User)USD6,650 ⇒환산￦8,977,500견적의뢰/주문/질문
Corporate LicenseUSD8,150 ⇒환산￦11,002,500견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
"글로벌 의약품 첨가제 시장은 2023년 107억 달러에서 2028년 149억 달러로 2023년부터 2028년까지 예측 기간 동안 6.8%의 CAGR을 기록할 것으로 예상됩니다."의약품 및 제네릭 의약품에 대한 수요 증가, 새로운 부형제 개발을 위한 R&D 투자 등의 요인이 향후 몇 년 동안 시장을 견인할 것으로 예상됩니다. 또한, 제약사와의 제휴 및 협력 관계, 환자 중심 처방에 대한 중요성이 높아지면서 시장 성장에 유리하게 작용할 것으로 보입니다. 그러나 엄격한 규제와 높은 개발 비용이 시장의 제약요인으로 작용할 것으로 예상됩니다.

"의약품 첨가제 시장에서 필러와 희석제의 기능성이 압도적인 점유율을 차지할 것으로 전망됩니다."
기능성에 따라 글로벌 의약품 첨가제 시장은 결합제, 현탁제 및 점성제, 충진제 및 희석제, 향료 및 감미료, 착색제, 코팅제, 윤활제 및 윤활성제, 방부제, 붕괴제, 유화제, 기타 기능성으로 구분됩니다. 고형 경구용 의약품의 개발 및 제조에서 필러 및 희석제에 대한 수요가 증가함에 따라 필러 및 희석제 시장의 성장을 견인할 것으로 예상됩니다. 제조업체의 경우, 필러와 희석제는 안정성을 제공하고 준비, 포장, 배송, 조제를 용이하게 합니다. 환자에게는 제제의 선호도를 높이고 약물의 투여 및 취급을 단순화합니다.

"2022년, 경구용 제제 부문이 제제 부문에서 가장 큰 점유율을 차지할 것입니다."
제형에 따라 의약품 첨가제 시장은 경구제, 외용제, 비경구제, 기타 제형으로 구분되며, 2022년에는 경구제 부문이 의약품 첨가제 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 급성장하는 바이오 의약품 산업과 제네릭 의약품 산업은 의약품 첨가제 시장의 성장을 이끄는 주요 원동력입니다. 또한, 경구 투여는 가장 일반적이고 전통적인 약물 전달 방법이며, 이 또한 이 분야의 성장에 기여하고 있습니다.

"아시아 태평양 지역은 더 빠른 속도로 성장할 가능성이 높습니다."
의약품 첨가제 시장은 북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카로 구분됩니다. 아시아 태평양은 예측 기간 동안 큰 CAGR로 성장할 것으로 예상됩니다. 저비용 제조의 이점, 낮은 규제, 1인당 소득 증가는 이 지역의 제약 첨가제 시장의 성장을 뒷받침하고 있습니다.

본 보고서를 위해 실시한 1차 인터뷰는 다음과 같이 분류됩니다.
- 응답자별 공급측 - 80%, 수요측 - 20%.
- 응답자 직급별 (공급측) 관리자 - 45%, CXO 및 이사 - 30%, 경영진 - 25%.
- 지역별로는 북미 -20%, 유럽 -10%, 아시아 태평양 -55%, 중남미 -10%, 중동/아프리카 -5%.

보고서 수록 기업 목록은 다음과 같습니다.
- International Flavors & Fragrances Inc. (US)
- Ashland Inc. (US)
- Evonik Industries AG (Germany)
- BASF SE (Germany)
- Kerry Group plc (Ireland)
- Roquette Frères (France)
- MERCK KGaA (Germany)
- Associated British Foods plc (UK)
- ADM (US)
- Wacker Chemie AG (Germany)
- Air Liquide (France)
- DOW (US)
- Berkshire Hathaway Inc. (US)
- Colorcon (US)
- DFE PHARMA (Germany)
- Innophos (US)
- JRS PHARMA (Germany)
- Actylis (US)
- Meggle GmbH & Co Kg (Germany)
- Corel Pharma Chem. (India)
- Biogrund GmbH (Germany)
- Nitika Pharmaceutical Specialities Pvt. Ltd. (India)
- BENEO (Germany)
- Fuji Chemical Industries Co., Ltd. (Japan)
- R.T. Vanderbilt Holding Company, Inc. (US)

연구 범위 :
이 보고서는 의약품 첨가제 시장에 대한 자세한 정보를 제공합니다. 제품, 기능성, 제형, 기능성 용도, 지역 등 다양한 부문의 시장 규모와 향후 성장 잠재력을 추정하는 것을 목표로 합니다. 또한 주요 시장 플레이어의 회사 개요, 최근 동향 및 주요 시장 전략과 함께 상세한 경쟁 분석도 제공합니다.

보고서 구매의 주요 이점 :
이 보고서는 전체 의약품 첨가제 시장과 그 하위 부문의 수익에 대한 가장 근접한 추정치를 제공함으로써 시장 리더와 신규 진입자를 지원합니다. 또한 이해 관계자가 경쟁 상황을 더 잘 이해하고 비즈니스를 더 잘 포지셔닝하고 적절한 시장 진입 전략을 수립하는 데 도움이되는 통찰력을 얻을 수 있습니다. 이 보고서를 통해 이해관계자들은 시장의 흐름을 이해하고 주요 시장 동인, 저해요인, 기회 및 과제에 대한 정보를 얻을 수 있습니다.

이 보고서는 다음 사항에 대한 통찰력을 제공합니다.
- 주요 촉진 요인(제네릭 및 의약품 수요 증가, 새로운 부형제 개발을 위한 R&D 투자 증가, 환자 중심 제형에 대한 관심 증가, 제약사와의 제휴 및 파트너십), 억제 요인(엄격한 규제 요건, 높은 개발 비용), 기회 요인(기능성/다기능성 의약품 첨가제 수요 증가, 나노 기술 발전, 아시아 태평양 및 중남미 신흥 시장), 도전 과제(안전성 및 품질 문제, 특정 원료의 가용성 제한)가 의약품 첨가제 시장 성장에 영향을 미치는 요인을 분석합니다.
- 제품 개발/혁신 : 의약품 첨가제 시장의 신제품에 대한 자세한 인사이트를 제공합니다.
- 기능성 용도 : 다양한 부형제의 용도에 따라 분류된 기능성 용도의 추가 세그먼트를 통해 다양한 부형제 클래스의 다양한 용도를 파악할 수 있습니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 이 보고서는 다양한 지역의 제약 첨가제 시장을 분석합니다.
- 시장 다각화 : 제약 첨가제 시장의 신규 서비스, 미개척 지역, 최근 개발 및 투자에 대한 자세한 정보를 제공합니다.
- 경쟁 평가 : International Flavors & Fragrances Inc. (미국), Ashland Inc. (미국), Evonik Industries AG (독일), BASF SE (독일), Kerry Group plc (아일랜드), Roquette Frères (프랑스), MERCK KGaA (독일), Associated British Foods plc (영국), ADM (미국), Wacker Chemie AG (독일) 등 의약품 첨가제 시장의 주요 기업의 시장 점유율, 성장 전략, 서비스 내용을 상세히 평가하고 있습니다.
■ 보고서 개요

1. 서론
2. 조사 방법
3. 개요
4. 프리미엄 인사이트
5. 시장 개요
6. 세계의 의약품 첨가제 시장 규모 : 제품별
7. 세계의 의약품 첨가제 시장 규모 : 제형별
8. 세계의 의약품 첨가제 시장 규모 : 기능별
9. 세계의 의약품 첨가제 시장 규모 : 용도별
10. 세계의 의약품 첨가제 시장 규모 : 지역별
11. 경쟁 현황
12. 기업 정보
13. 부록

■ 보고서 목차

1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS AND EXCLUSIONS 44
1.3 MARKET SCOPE 45
1.3.1 MARKETS COVERED 45
1.3.2 YEARS CONSIDERED 46
1.3.3 CURRENCY CONSIDERED 46
1.4 STAKEHOLDERS 46
1.5 SUMMARY OF CHANGES 47
1.5.1 RECESSION IMPACT 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
FIGURE 1 RESEARCH DESIGN 49
2.1.1 SECONDARY DATA 50
2.1.2 PRIMARY DATA 51
FIGURE 2 BREAKDOWN OF PRIMARIES 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 3 MARKET SIZE ESTIMATION: PHARMACEUTICAL EXCIPIENTS MARKET (2022) 52
FIGURE 4 APPROACH 1: REVENUE SHARE ANALYSIS 53
FIGURE 5 REVENUE SHARE ANALYSIS OF INTERNATIONAL FLAVORS & FRAGRANCES INC.: PHARMACEUTICAL EXCIPIENTS MARKET (2022) 53
2.2.1 PRIMARY INSIGHTS 54
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 54
2.2.2 SEGMENTAL ASSESSMENT: PHARMACEUTICAL EXCIPIENTS MARKET 55
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 55
2.3 GROWTH RATE ASSUMPTIONS 56
FIGURE 8 CAGR PROJECTION: PHARMACEUTICAL EXCIPIENTS MARKET 56
FIGURE 9 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 57
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 10 DATA TRIANGULATION METHODOLOGY 58
2.5 STUDY ASSUMPTIONS 59
2.6 RESEARCH LIMITATIONS 59
2.7 RISK ANALYSIS 60
2.8 RECESSION IMPACT: PHARMACEUTICAL EXCIPIENTS MARKET 60
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021–2028 (% GROWTH) 61
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 61
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 61
3 EXECUTIVE SUMMARY 62
FIGURE 11 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 62
FIGURE 12 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION) 63
FIGURE 13 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION) 64
FIGURE 14 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION) 64
FIGURE 15 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHICAL SNAPSHOT 65
4 PREMIUM INSIGHTS 66
4.1 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW 66
FIGURE 16 GROWTH IN GENERICS AND PHARMACEUTICAL PRODUCT DEMAND TO DRIVE MARKET GROWTH 66
4.2 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET 67
FIGURE 17 ORGANIC CHEMICALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 67
4.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 19 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
TABLE 4 PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS 69
5.2.1 DRIVERS 69
5.2.1.1 Increasing demand for generic drugs and pharmaceutical products 69
TABLE 5 BRAND NAMES AND GENERIC COUNTERPARTS 70
5.2.1.2 Increased R&D investments to develop novel excipients 71
FIGURE 20 GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022) 71
5.2.1.3 Growing emphasis on patient-centric formulations to fuel demand for specialized excipients 72
5.2.1.4 Collaborations and partnerships with pharmaceutical companies for customized excipient solutions 72
5.2.2 RESTRAINTS 73
5.2.2.1 Stringent regulatory requirements 73
5.2.2.2 High development costs 74
5.2.3 OPPORTUNITIES 74
5.2.3.1 Rising demand for functional/multifunctional pharmaceutical excipients 74
TABLE 6 MULTIFUNCTIONAL EXCIPIENTS 75
5.2.3.2 Advancements in nanotechnology 76
5.2.3.3 Emerging markets in Asia Pacific and Latin America 77
5.2.4 CHALLENGES 78
5.2.4.1 Safety and quality concerns 78
5.2.4.2 Limited availability of certain raw materials used in excipient production 78
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79
FIGURE 21 REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENT PROVIDERS 79
5.4 PRICING ANALYSIS 80
TABLE 7 PRICING ANALYSIS (USD) 80
5.5 VALUE CHAIN ANALYSIS 80
FIGURE 22 PHARMACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS 82
FIGURE 23 PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS 83
5.6 ECOSYSTEM/MARKET MAP 84
FIGURE 24 PHARMACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM/MARKET MAP 84
TABLE 8 SUPPLY CHAIN ECOSYSTEM 84
5.7 TECHNOLOGY ANALYSIS 86
5.8 PATENT ANALYSIS 87
FIGURE 25 PHARMACEUTICAL EXCIPIENTS MARKET: PATENT ANALYSIS 87
5.8.1 LIST OF MAJOR PATENTS 88
TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET: MAJOR PATENTS 88
5.9 KEY CONFERENCES & EVENTS IN 2023–2024 89
TABLE 10 PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF EVENTS AND CONFERENCES 89
5.10 TRADE DATA 90
5.10.1 GLYCEROL 90
TABLE 11 HS CODE: 290545 GLYCEROL 90
5.10.2 DEXTRINS AND OTHER MODIFIED STARCHES 92
TABLE 12 HS CODE: 350510 DEXTRINS AND OTHER MODIFIED STARCHES (E.G., PREGELATINIZED OR ESTERIFIED STARCHES) 92
5.10.3 PROPYLENE GLYCOL 94
TABLE 13 HS CODE: 290532 PROPYLENE GLYCOL (PROPANE-1,2-DIOL) 94
5.10.4 CALCIUM CARBONATE 96
TABLE 14 HS CODE: 283650 CALCIUM CARBONATE 96
5.10.5 SODIUM CHLORIDE 98
TABLE 15 HS CODE: 250100 SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE, WHETHER OR NOT IN AQUEOUS SOLUTION OR CONTAINING ADDED ANTI-CAKING OR FREE-FLOWING AGENTS; SEA WATER 98
5.10.6 MANNITOL 100
TABLE 16 HS CODE: 290543 MANNITOL 100
5.10.7 CELLULOSE 102
TABLE 17 HS CODE: 3912 CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS 102
5.11 TARIFF AND REGULATORY LANDSCAPE 103
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 103
5.11.1.1 FDA regulations on pharmaceutical excipients 103
5.11.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
5.11.2.1 North America 104
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
5.11.2.2 Europe 105
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
5.11.2.3 Asia Pacific 106
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
5.11.2.4 Latin America 106
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
5.11.2.5 Middle East & Africa 107
TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
5.12 PORTER’S FIVE FORCES ANALYSIS 107
TABLE 23 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 107
5.12.1 THREAT OF NEW ENTRANTS 107
5.12.2 THREAT OF SUBSTITUTES 107
5.12.3 BARGAINING POWER OF BUYERS 108
5.12.4 BARGAINING POWER OF SUPPLIERS 108
5.12.5 DEGREE OF COMPETITION 108
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
FIGURE 26 INFLUENCE OF COMPANY STAKEHOLDERS IN BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS 108
5.13.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENTS PRODUCTS AMONG END USERS 109
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 109
6 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 110
6.1 INTRODUCTION 111
TABLE 24 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 111
6.2 ORGANIC CHEMICALS 111
TABLE 25 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 26 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 27 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 28 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 29 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 30 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.2.1 OLEOCHEMICALS 113
TABLE 31 OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 32 OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 33 NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 34 EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 35 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 36 LATIN AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.2.1.1 Fatty alcohols 116
6.2.1.1.1 Wide usage as nonionic surfactants to drive market 116
TABLE 37 FATTY ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 38 NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 39 EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 40 ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 41 LATIN AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.2.1.2 Mineral stearates 118
6.2.1.2.1 High adoption of magnesium stearates as excipients in to drive market 118
TABLE 42 MINERAL STEARATES MARKET, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 43 NORTH AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 44 EUROPE: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 45 ASIA PACIFIC MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 46 LATIN AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.2.1.3 Glycerin 120
6.2.1.3.1 Extensive applications of glycerin to drive market 120
TABLE 47 GLYCERIN MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 48 NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 49 EUROPE: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 50 ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 51 LATIN AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.2.1.4 Other oleochemicals 122
TABLE 52 OTHER OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 53 NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 54 EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 55 ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 56 LATIN AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
6.2.2 CARBOHYDRATES 124
TABLE 57 CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 58 CARBOHYDRATES MARKET, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 59 NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 60 EUROPE: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 61 ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 62 LATIN AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.2.2.1 Sugars 127
TABLE 63 SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 64 SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 65 NORTH AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 66 EUROPE: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 67 ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 68 LATIN AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
6.2.2.2 Actual sugars 129
6.2.2.2.1 Growing use of actual sugars in pediatric formulations to drive market 129
TABLE 69 PHARMACEUTICAL EXCIPIENTS MARKET, BY ACTUAL SUGARS, 2021–2028 (USD MILLION) 130
TABLE 70 ACTUAL SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 71 NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 72 EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 73 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 74 LATIN AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
6.2.2.3 Sugar alcohols 132
6.2.2.3.1 Mannitol to show highest growth in sugar alcohols market 132
TABLE 75 PHARMACEUTICAL EXCIPIENTS MARKET, BY SUGAR ALCOHOLS, 2021–2028 (USD MILLION) 133
TABLE 76 SUGAR ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 77 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 78 EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 79 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 80 LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
6.2.2.4 Artificial sweeteners 135
6.2.2.4.1 Wide usage of aspartame to ensure sustained growth 135
TABLE 81 ARTIFICIAL SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 82 NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 83 EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 84 ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 85 LATIN AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
6.2.2.5 Cellulose 137
TABLE 86 CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 87 CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 88 NORTH AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 89 EUROPE: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 90 ASIA PACIFIC: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 91 LATIN AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
6.2.2.6 Microcrystalline cellulose 140
6.2.2.6.1 Microcrystalline cellulose to hold largest share 140
TABLE 92 MICROCRYSTALLINE CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 93 NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 94 EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 95 ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 96 LATIN AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
6.2.2.7 Cellulose ethers 142
6.2.2.7.1 Effectiveness in low concentrations to propel usage 142
TABLE 97 CELLULOSE ETHERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 98 NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 99 EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 100 ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 101 LATIN AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
6.2.2.8 CMC & croscarmellose sodium 144
6.2.2.8.1 Advantages to ensure wide usage as suspending agents in injectable preparations 144
TABLE 102 CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 103 NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 104 EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 105 ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 106 LATIN AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
6.2.2.9 Cellulose esters 147
6.2.2.9.1 Wide usage in pharma applications to support market growth 147
TABLE 107 CELLULOSE ESTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 108 NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 109 EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 110 ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 111 LATIN AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
6.2.2.10 Starch 149
TABLE 112 STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 113 STARCH MARKET, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 114 NORTH AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 115 EUROPE: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 116 ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 117 LATIN AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
6.2.2.11 Modified starch 151
6.2.2.11.1 Wide use in sustained-release tablets attributed to cold-water swelling and gel barrier formation capabilities 151
TABLE 118 MODIFIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION) 152
TABLE 119 NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 120 EUROPE: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 121 ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 122 LATIN AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
6.2.2.12 Dried starch 153
6.2.2.12.1 Strong binding and coating properties to favor demand growth 153
TABLE 123 DRIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 124 NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 125 EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 126 ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 127 LATIN AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
6.2.2.13 Converted starch 155
6.2.2.13.1 Support for enhancing drug solubility and stability to propel adoption 155
TABLE 128 CONVERTED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 129 NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 130 EUROPE: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 131 ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 132 LATIN AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
6.2.3 PETROCHEMICALS 157
TABLE 133 PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 134 PETROCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 135 NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 136 EUROPE: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 137 ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 138 LATIN AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
6.2.3.1 Glycols 160
6.2.3.1.1 Glycols to hold largest share of petrochemicals segment 160
TABLE 139 PHARMACEUTICAL EXCIPIENTS MARKET, BY GLYCOLS, 2021–2028 (USD MILLION) 160
TABLE 140 GLYCOLS MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 141 NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 142 EUROPE: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 143 ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 144 LATIN AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
6.2.3.2 Povidones 162
6.2.3.2.1 Rising demand for fast-dissolving tablets to propel market growth 162
TABLE 145 POVIDONES MARKET, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 146 NORTH AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 147 EUROPE: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 148 ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 149 LATIN AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
6.2.3.3 Mineral hydrocarbons 164
6.2.3.3.1 Growing preference for topical formulations in pain management to support demand for mineral hydrocarbons 164
TABLE 150 PHARMACEUTICAL EXCIPIENTS MARKET, BY MINERAL HYDROCARBONS, 2021–2028 (USD MILLION) 165
TABLE 151 MINERAL HYDROCARBONS MARKET, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 152 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 153 EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 154 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 155 LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
6.2.3.4 Acrylic polymers 167
6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market 167
TABLE 156 ACRYLIC POLYMERS MARKET, BY REGION, 2021–2028 (USD MILLION) 167
TABLE 157 NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 158 EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 159 ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 160 LATIN AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 169
6.2.3.5 Other petrochemical excipients 169
TABLE 161 OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 162 NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 163 EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 164 ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 165 LATIN AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
6.2.4 PROTEINS 172
6.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to drive market 172
TABLE 166 PROTEINS MARKET, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 167 NORTH AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 168 EUROPE: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 169 ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 170 LATIN AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
6.2.5 OTHER ORGANIC CHEMICALS 174
TABLE 171 OTHER ORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 172 NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 173 EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 174 ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 175 LATIN AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
6.3 INORGANIC CHEMICALS 176
TABLE 176 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 177 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION) 177
TABLE 178 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 179 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 180 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 181 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 178
6.3.1 CALCIUM PHOSPHATE 178
6.3.1.1 Chemical purity and low incompatibility with drugs to aid usage in pharma applications 178
TABLE 182 CALCIUM PHOSPHATE MARKET, BY REGION, 2021–2028 (USD MILLION) 179
TABLE 183 NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 184 EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 185 ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 186 LATIN AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
6.3.2 METAL OXIDES 180
6.3.2.1 Availability of silicon oxides in hydrophobic, hydrophilic, and granulated forms to aid market growth 180
TABLE 187 METAL OXIDES MARKET, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 188 NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 189 EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 190 ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 191 LATIN AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
6.3.3 HALITES 182
6.3.3.1 Increased utilization in vaccines and controlled-release formulations to drive demand 182
TABLE 192 HALITES MARKET, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 193 NORTH AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 194 EUROPE: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 195 ASIA PACIFIC: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 196 LATIN AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
6.3.4 CALCIUM CARBONATE 184
6.3.4.1 Short disintegration time and excellent mechanical strength for oral formulations to drive market 184
TABLE 197 CALCIUM CARBONATE MARKET, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 198 NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 199 EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 200 ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 201 LATIN AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
6.3.5 CALCIUM SULFATE 186
6.3.5.1 Cost-effectiveness as diluent to support adoption 186
TABLE 202 CALCIUM SULFATE MARKET, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 203 NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 204 EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 205 ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 206 LATIN AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188
6.3.6 OTHER INORGANIC CHEMICALS 188
TABLE 207 OTHER INORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 208 NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 209 EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 210 ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 211 LATIN AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 190
6.4 OTHER CHEMICALS 190
TABLE 212 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2021–2028 (USD MILLION) 191
TABLE 213 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 214 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 215 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 216 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 192
7 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 193
7.1 INTRODUCTION 194
TABLE 217 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 194
7.2 ORAL FORMULATIONS 194
TABLE 218 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 219 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 220 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 221 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 222 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 223 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 196
7.2.1 TABLETS 197
7.2.1.1 Wide usage to drive market 197
TABLE 224 TYPICAL COMPOSITION OF TABLETS 197
TABLE 225 TABLETS MARKET, BY REGION, 2021–2028 (USD MILLION) 198
TABLE 226 NORTH AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 227 EUROPE: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 228 ASIA PACIFIC: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 229 LATIN AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199
7.2.2 CAPSULES 199
TABLE 230 CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 231 CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 200
TABLE 232 NORTH AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 233 EUROPE: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 234 ASIA PACIFIC: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 235 LATIN AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
7.2.2.1 Hard-gelatin capsules 202
7.2.2.1.1 Ease of manufacturing and versatility to drive market 202
TABLE 236 HARD-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 202
TABLE 237 NORTH AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 238 EUROPE: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 239 ASIA PACIFIC: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 240 LATIN AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 203
7.2.2.2 Soft-gelatin capsules 204
7.2.2.2.1 Stability concerns with highly water-soluble compounds to restrict growth 204
TABLE 241 SOFT-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 204
TABLE 242 NORTH AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 243 EUROPE: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 244 ASIA PACIFIC: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 245 LATIN AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 206
7.2.3 LIQUID FORMULATIONS 206
7.2.3.1 No dissolution time and rapid absorption to favor adoption 206
TABLE 246 LIQUID FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 206
TABLE 247 NORTH AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 248 EUROPE: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 249 ASIA PACIFIC: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 250 LATIN AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 208
7.2.4 OTHER ORAL FORMULATIONS 208
TABLE 251 OTHER ORAL FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 209
TABLE 252 NORTH AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 253 EUROPE: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 254 ASIA PACIFIC: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 210
TABLE 255 LATIN AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 210
7.3 TOPICAL FORMULATIONS 210
7.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY TO DRIVE MARKET 210
TABLE 256 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION) 211
TABLE 257 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 258 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 259 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 260 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 212

7.4 PARENTERAL FORMULATIONS 213
7.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE DEMAND FOR EXCIPIENTS 213
TABLE 261 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS 213
TABLE 262 EXCIPIENTS USED IN PARENTERAL FORMULATIONS 214
TABLE 263 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION) 215
TABLE 264 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 215
TABLE 265 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 215
TABLE 266 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 267 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 216
7.5 OTHER FORMULATIONS 216
TABLE 268 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2021–2028 (USD MILLION) 217
TABLE 269 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 270 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 271 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 272 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 218
8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 219
8.1 INTRODUCTION 220
TABLE 273 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 220
8.2 FILLERS & DILUENTS 220
8.2.1 IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW PROPERTIES TO SUPPORT ADOPTION 220
TABLE 274 FILLERS & DILUENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 221
TABLE 275 NORTH AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222
TABLE 276 EUROPE: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222
TABLE 277 ASIA PACIFIC: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222
TABLE 278 LATIN AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 223
8.3 SUSPENDING & VISCOSITY AGENTS 223
8.3.1 DRUG STABILITY AND TASTE-MASKING ADVANTAGES TO SUPPORT DEMAND 223
TABLE 279 SUSPENDING & VISCOSITY AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 224
TABLE 280 NORTH AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 281 EUROPE: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 282 ASIA PACIFIC: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 225
TABLE 283 LATIN AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 225
8.4 COATING AGENTS 225
8.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET 225
TABLE 284 COATING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 227
TABLE 285 NORTH AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 227
TABLE 286 EUROPE: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 227
TABLE 287 ASIA PACIFIC: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 228
TABLE 288 LATIN AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 228
8.5 BINDERS 228
8.5.1 FLUIDITY AND COMPRESSIBILITY IN TABLET MANUFACTURING TO DRIVE DEMAND 228
TABLE 289 BINDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 229
TABLE 290 NORTH AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 291 EUROPE: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 292 ASIA PACIFIC: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 293 LATIN AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 231
8.6 FLAVORING AGENTS & SWEETENERS 231
8.6.1 NEED TO IMPROVE DRUG PALATABILITY TO SUPPORT USAGE 231
TABLE 294 FLAVORING AGENTS & SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION) 232
TABLE 295 NORTH AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 296 EUROPE: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 297 ASIA PACIFIC: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 233
TABLE 298 LATIN AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 233
8.7 DISINTEGRANTS 233
8.7.1 NEED TO ENSURE RAPID BREAK-UP OF SOLID DOSAGE FORMS TO DRIVE ADOPTION 233
TABLE 299 DISINTEGRANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 234
TABLE 300 NORTH AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 234
TABLE 301 EUROPE: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235
TABLE 302 ASIA PACIFIC: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235
TABLE 303 LATIN AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235
8.8 COLORANTS 236
8.8.1 APPLICATIONS IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO DRIVE MARKET 236
TABLE 304 COLORANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 237
TABLE 305 NORTH AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 237
TABLE 306 EUROPE: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 237
TABLE 307 ASIA PACIFIC: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 238
TABLE 308 LATIN AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 238
8.9 LUBRICANTS & GLIDANTS 238
8.9.1 NEED TO LESSEN WEAR AND TEAR ON FORMULATIONS TO SUPPORT LUBRICANT USAGE 238
TABLE 309 LUBRICANTS & GLIDANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 239
TABLE 310 NORTH AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 239
TABLE 311 EUROPE: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 240
TABLE 312 ASIA PACIFIC: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 240
TABLE 313 LATIN AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 240
8.10 PRESERVATIVES 241
8.10.1 PRESERVATIVES TO SEE SUSTAINED USAGE TO ENSURE LONGER SHELF-LIFE 241
TABLE 314 PRESERVATIVES MARKET, BY REGION, 2021–2028 (USD MILLION) 241
TABLE 315 NORTH AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 242
TABLE 316 EUROPE: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 242
TABLE 317 ASIA PACIFIC: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 242
TABLE 318 LATIN AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 243
8.11 EMULSIFYING AGENTS 243
8.11.1 HIGH USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID FORMULATIONS TO DRIVE MARKET 243
TABLE 319 EMULSIFYING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 244
TABLE 320 NORTH AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 244
TABLE 321 EUROPE: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 244
TABLE 322 ASIA PACIFIC: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 245
TABLE 323 LATIN AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 245
8.12 OTHER FUNCTIONALITIES 245
TABLE 324 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021–2028 (USD MILLION) 247
TABLE 325 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION) 247
TABLE 326 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION) 247
TABLE 327 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION) 248
TABLE 328 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION) 248
9 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 249
9.1 INTRODUCTION 250
TABLE 329 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 250
9.2 STABILIZERS 250
9.2.1 IMPROVED DRUG SHELF LIFE AND REDUCED MANUFACTURING DEFECTS TO DRIVE MARKET 250
TABLE 330 PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2021–2028 (USD MILLION) 251
TABLE 331 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 251
TABLE 332 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 252
TABLE 333 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 252
TABLE 334 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 252
9.3 TASTE MASKING 253
9.3.1 GREATER PATIENT COMPLIANCE AND ADHERENCE ADVANTAGES TO ENSURE ADOPTION 253
TABLE 335 PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2021–2028 (USD MILLION) 253
TABLE 336 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 254
TABLE 337 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 254
TABLE 338 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 254
TABLE 339 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 255
9.4 MODIFIED RELEASE 255
9.4.1 INCREASING USE OF MODIFIED-RELEASE FORMULATIONS TO DRIVE MARKET 255
TABLE 340 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2021–2028 (USD MILLION) 256
TABLE 341 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION) 256
TABLE 342 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION) 256
TABLE 343 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION) 257
TABLE 344 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION) 257
9.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 257
9.5.1 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT EXCIPIENTS ESSENTIAL FOR EFFECTIVE DRUG DELIVERY 257
TABLE 345 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2021–2028 (USD MILLION) 258
TABLE 346 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 259
TABLE 347 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 259
TABLE 348 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 259
TABLE 349 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 260
9.6 OTHER FUNCTIONALITY APPLICATIONS 260
TABLE 350 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 260
TABLE 351 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 352 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 353 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 354 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 262
10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION 263
10.1 INTRODUCTION 264
TABLE 355 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 264
10.2 EUROPE 264
FIGURE 28 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 265
10.2.1 EUROPE: RECESSION IMPACT 266
TABLE 356 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 266
TABLE 357 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 266
TABLE 358 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 359 EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 360 EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 361 EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 362 EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 363 EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 364 EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 365 EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 366 EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 367 EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 368 EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 369 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 370 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 271
TABLE 371 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 271
TABLE 372 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 373 EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 374 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 272
10.2.2 GERMANY 273
10.2.2.1 Germany to hold largest market share in Europe 273
TABLE 375 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 273
TABLE 376 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 377 GERMANY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 378 GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 379 GERMANY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 380 GERMANY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 381 GERMANY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 382 GERMANY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 383 GERMANY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 384 GERMANY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 385 GERMANY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 386 GERMANY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 387 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 388 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 278
TABLE 389 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 278
TABLE 390 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 391 GERMANY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 392 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 279
10.2.3 UK 280
10.2.3.1 Growing adoption of generics and development of multi-functional, co-processed excipients to drive market 280
TABLE 393 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 280
TABLE 394 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 395 UK: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 396 UK: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 397 UK: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 398 UK: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 399 UK: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 400 UK: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 401 UK: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 402 UK: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 403 UK: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 404 UK: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 405 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 406 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 285
TABLE 407 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 285
TABLE 408 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 409 UK: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 410 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 286
10.2.4 FRANCE 287
10.2.4.1 Large geriatric population to support market growth 287
TABLE 411 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 287
TABLE 412 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 413 FRANCE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 414 FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 415 FRANCE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 416 FRANCE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 417 FRANCE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 418 FRANCE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 419 FRANCE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 420 FRANCE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 421 FRANCE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 422 FRANCE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 423 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 424 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 292
TABLE 425 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 292
TABLE 426 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 427 FRANCE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 428 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 293
10.2.5 ITALY 294
10.2.5.1 Budgetary constraints and restricted healthcare spending to impede growth 294
TABLE 429 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 294
TABLE 430 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 431 ITALY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 432 ITALY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 433 ITALY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 434 ITALY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 435 ITALY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 436 ITALY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 437 ITALY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 438 ITALY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 439 ITALY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 440 ITALY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 441 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 442 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 299
TABLE 443 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 299
TABLE 444 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 445 ITALY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 446 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 300
10.2.6 SPAIN 301
10.2.6.1 High consumption of biologics to support market growth 301
TABLE 447 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 301
TABLE 448 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 449 SPAIN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 450 SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 451 SPAIN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 452 SPAIN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 453 SPAIN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 454 SPAIN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 304
TABLE 455 SPAIN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 304
TABLE 456 SPAIN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 304
TABLE 457 SPAIN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 458 SPAIN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 459 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 460 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 306
TABLE 461 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 306
TABLE 462 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 463 SPAIN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 464 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 307
10.2.7 REST OF EUROPE 308
TABLE 465 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 308
TABLE 466 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 467 REST OF EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 468 REST OF EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 469 REST OF EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 470 REST OF EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 471 REST OF EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 472 REST OF EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 473 REST OF EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 474 REST OF EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 475 REST OF EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 476 REST OF EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 477 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 478 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 313
TABLE 479 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 313
TABLE 480 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 481 REST OF EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 482 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 314
10.3 NORTH AMERICA 315
10.3.1 NORTH AMERICA: RECESSION IMPACT 315
FIGURE 29 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 316
TABLE 483 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 316
TABLE 484 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 317
TABLE 485 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 486 NORTH AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 487 NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 488 NORTH AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 489 NORTH AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 490 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 491 NORTH AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 492 NORTH AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 493 NORTH AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 494 NORTH AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 495 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 496 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 321
TABLE 497 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 321
TABLE 498 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 322
TABLE 499 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 322
TABLE 500 NORTH AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 322
TABLE 501 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 323
10.3.2 US 323
10.3.2.1 US to dominate North American market 323
TABLE 502 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 324
TABLE 503 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 504 US: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 505 US: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 506 US: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 507 US: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 508 US: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 509 US: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 510 US: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 511 US: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 512 US: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 513 US: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 514 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 515 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 328
TABLE 516 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 329
TABLE 517 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 518 US: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 519 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 330
10.3.3 CANADA 330
10.3.3.1 Strong growth of emerging markets and slowdown in new product approvals to hamper growth 330
TABLE 520 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 331
TABLE 521 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 522 CANADA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 523 CANADA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 524 CANADA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 525 CANADA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 526 CANADA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 333
TABLE 527 CANADA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 333
TABLE 528 CANADA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 333
TABLE 529 CANADA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 530 CANADA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 531 CANADA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 532 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 533 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 335
TABLE 534 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 336
TABLE 535 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 536 CANADA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 537 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 337

10.4 ASIA PACIFIC 337
10.4.1 ASIA PACIFIC: RECESSION IMPACT 337
TABLE 538 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 338
TABLE 539 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 338
TABLE 540 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 541 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 542 ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 543 ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 544 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 545 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 546 ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 547 ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 548 ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 549 ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 550 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 551 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 552 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 343
TABLE 553 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 343
TABLE 554 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 555 ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 556 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 344
10.4.2 CHINA 345
10.4.2.1 Emphasis on generics and off-patent drugs to drive market 345
TABLE 557 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 345
TABLE 558 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 559 CHINA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 560 CHINA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 561 CHINA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 562 CHINA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 563 CHINA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 564 CHINA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 565 CHINA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 566 CHINA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 567 CHINA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 349
TABLE 568 CHINA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 349
TABLE 569 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 349
TABLE 570 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 350
TABLE 571 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 350
TABLE 572 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 573 CHINA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 574 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 351
10.4.3 JAPAN 352
10.4.3.1 Rapid growth in geriatric population to drive demand for pharmaceuticals 352
TABLE 575 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 352
TABLE 576 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 577 JAPAN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 578 JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 579 JAPAN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 580 JAPAN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 581 JAPAN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 582 JAPAN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 583 JAPAN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 584 JAPAN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 585 JAPAN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 586 JAPAN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 587 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 588 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 357
TABLE 589 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 357
TABLE 590 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 358
TABLE 591 JAPAN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 358
TABLE 592 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 358
10.4.4 INDIA 359
10.4.4.1 High generics production to support market growth 359
TABLE 593 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 359
TABLE 594 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 595 INDIA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 596 INDIA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 597 INDIA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 598 INDIA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 599 INDIA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 600 INDIA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 601 INDIA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 602 INDIA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 603 INDIA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 363
TABLE 604 INDIA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 363
TABLE 605 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 363
TABLE 606 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 364
TABLE 607 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 364
TABLE 608 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 365
TABLE 609 INDIA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 365
TABLE 610 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 365
10.4.5 SOUTH KOREA 366
10.4.5.1 Strong and growing pharma industry to ensure market growth 366
TABLE 611 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 366
TABLE 612 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 366
TABLE 613 SOUTH KOREA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 614 SOUTH KOREA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 615 SOUTH KOREA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 616 SOUTH KOREA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 617 SOUTH KOREA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 618 SOUTH KOREA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 619 SOUTH KOREA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 369
TABLE 620 SOUTH KOREA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 369
TABLE 621 SOUTH KOREA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 369
TABLE 622 SOUTH KOREA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 623 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 624 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 371
TABLE 625 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 371
TABLE 626 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 372
TABLE 627 SOUTH KOREA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 372
TABLE 628 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 372
10.4.6 REST OF ASIA PACIFIC 373
TABLE 629 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 373
TABLE 630 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 374
TABLE 631 REST OF ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 374
TABLE 632 REST OF ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 374
TABLE 633 REST OF ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 634 REST OF ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 635 REST OF ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 636 REST OF ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 637 REST OF ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 638 REST OF ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 639 REST OF ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 377
TABLE 640 REST OF ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 377
TABLE 641 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 377
TABLE 642 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 378
TABLE 643 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 378
TABLE 644 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 379
TABLE 645 REST OF ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 379
TABLE 646 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 379
 
10.5 LATIN AMERICA 380
10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE TO DRIVE MARKET 380
10.5.2 LATIN AMERICA: RECESSION IMPACT 380
TABLE 647 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 380
TABLE 648 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 381
TABLE 649 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 381
TABLE 650 LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 381
TABLE 651 LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 382
TABLE 652 LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 382
TABLE 653 LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 382
TABLE 654 LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 655 LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 656 LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 657 LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 658 LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 659 LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 660 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 385
TABLE 661 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 385
TABLE 662 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 386
TABLE 663 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 664 LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 665 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 387
10.5.3 BRAZIL 387
10.5.3.1 Brazil to hold largest share in LATAM market 387
TABLE 666 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 387
TABLE 667 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 388
TABLE 668 BRAZIL: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 388
TABLE 669 BRAZIL: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 388
TABLE 670 BRAZIL: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 389
TABLE 671 BRAZIL: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 389
TABLE 672 BRAZIL: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 389
TABLE 673 BRAZIL: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 390
TABLE 674 BRAZIL: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 390
TABLE 675 BRAZIL: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 390
TABLE 676 BRAZIL: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 677 BRAZIL: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 678 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 679 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 392
TABLE 680 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 392
TABLE 681 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 393
TABLE 682 BRAZIL: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 393
TABLE 683 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 393
10.5.4 REST OF LATIN AMERICA 394
TABLE 684 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 394
TABLE 685 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 394
TABLE 686 REST OF LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 395
TABLE 687 REST OF LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 395
TABLE 688 REST OF LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 395
TABLE 689 REST OF LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 396
TABLE 690 REST OF LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 396
TABLE 691 REST OF LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 396
TABLE 692 REST OF LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 397
TABLE 693 REST OF LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 397
TABLE 694 REST OF LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 397
TABLE 695 REST OF LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 696 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 697 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 399
TABLE 698 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 399
TABLE 699 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 400
TABLE 700 REST OF LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 400
TABLE 701 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 400
10.6 MIDDLE EAST & AFRICA 401
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 401
10.6.2 MIDDLE EAST 401
10.6.2.1 Growing attention from global players to favor growth of middle eastern markets 401
TABLE 702 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 401
TABLE 703 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 402
TABLE 704 MIDDLE EAST: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 402
TABLE 705 MIDDLE EAST: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 402
TABLE 706 MIDDLE EAST: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 707 MIDDLE EAST: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 708 MIDDLE EAST: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 709 MIDDLE EAST: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 404
TABLE 710 MIDDLE EAST: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 404
TABLE 711 MIDDLE EAST: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 404
TABLE 712 MIDDLE EAST: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 405
TABLE 713 MIDDLE EAST: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 405
TABLE 714 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 405
TABLE 715 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 406
TABLE 716 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 406
TABLE 717 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 718 MIDDLE EAST: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 719 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 407
10.6.3 AFRICA 408
10.6.3.1 Rising urbanization, growing healthcare access to offer growth opportunities 408
TABLE 720 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 408
TABLE 721 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 408
TABLE 722 AFRICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 723 AFRICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 724 AFRICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 725 AFRICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 410
TABLE 726 AFRICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 410
TABLE 727 AFRICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 410
TABLE 728 AFRICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 411
TABLE 729 AFRICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 411
TABLE 730 AFRICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 411
TABLE 731 AFRICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 412
TABLE 732 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION) 412
TABLE 733 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 413
TABLE 734 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 413
TABLE 735 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION) 414
TABLE 736 AFRICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 414
TABLE 737 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION) 414
11 COMPETITIVE LANDSCAPE 415
11.1 INTRODUCTION 415
11.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN 415
FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS 415
11.3 REVENUE SHARE ANALYSIS 416
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS (2020–2022) 416
11.4 MARKET SHARE ANALYSIS 416
FIGURE 32 PHARMACEUTICAL EXCIPIENTS MARKET: MARKET SHARE ANALYSIS (2022) 417
TABLE 738 PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION 417
11.5 COMPANY EVALUATION MATRIX 418
11.5.1 STARS 419
11.5.2 EMERGING LEADERS 419
11.5.3 PERVASIVE PLAYERS 419
11.5.4 PARTICIPANTS 419
FIGURE 33 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX, 2022 420
11.5.5 COMPANY FOOTPRINT 421
TABLE 739 PRODUCT FOOTPRINT (25 COMPANIES) 421
TABLE 740 REGIONAL FOOTPRINT (25 COMPANIES) 422
11.6 START-UP/SME EVALUATION MATRIX 423
11.6.1 PROGRESSIVE COMPANIES 423
11.6.2 STARTING BLOCKS 423
11.6.3 RESPONSIVE COMPANIES 423
11.6.4 DYNAMIC COMPANIES 423
FIGURE 34 PHARMACEUTICAL EXCIPIENTS MARKET: START-UP/SME MATRIX, 2022 424
11.6.5 COMPETITIVE BENCHMARKING 425
TABLE 741 PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 425
TABLE 742 PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 426
11.7 COMPETITIVE SCENARIO AND TRENDS 426
11.7.1 PRODUCT LAUNCHES 426
TABLE 743 PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO DECEMBER 2023 426
11.7.2 DEALS 427
TABLE 744 PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2020 TO DECEMBER 2023 427
11.7.3 OTHER DEVELOPMENTS 428
TABLE 745 PHARMACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO DECEMBER 2023 428
12 COMPANY PROFILES 429
(Business overview, Products/Solutions/Services offered, Recent developments & MnM Vie
12.1 KEY PLAYERS 429
12.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC. 429
TABLE 746 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 429
FIGURE 35 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT (2022) 430
12.1.2 BASF SE 433
TABLE 747 BASF SE: BUSINESS OVERVIEW 433
FIGURE 36 BASF SE: COMPANY SNAPSHOT (2022) 433
12.1.3 ASHLAND INC. 438
TABLE 748 ASHLAND INC.: BUSINESS OVERVIEW 438
FIGURE 37 ASHLAND INC.: COMPANY SNAPSHOT (2022) 439
12.1.4 EVONIK INDUSTRIES AG 444
TABLE 749 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW 444
FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2022) 445
12.1.5 KERRY GROUP PLC 447
TABLE 750 KERRY GROUP PLC: BUSINESS OVERVIEW 447
FIGURE 39 KERRY GROUP PLC: COMPANY SNAPSHOT (2022) 448
12.1.6 ROQUETTE FRÈRES 450
TABLE 751 ROQUETTE FRÈRES: BUSINESS OVERVIEW 450
12.1.7 MERCK KGAA 456
TABLE 752 MERCK KGAA: BUSINESS OVERVIEW 456
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022) 456
12.1.8 ASSOCIATED BRITISH FOODS PLC 459
TABLE 753 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 459
FIGURE 41 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2022) 460
12.1.9 ADM 464
TABLE 754 ADM: BUSINESS OVERVIEW 464
FIGURE 42 ADM: COMPANY SNAPSHOT (2022) 465
12.1.10 WACKER CHEMIE AG 467
TABLE 755 WACKER CHEMIE AG: BUSINESS OVERVIEW 467
FIGURE 43 WACKER CHEMIE AG: COMPANY SNAPSHOT (2022) 468
12.1.11 AIR LIQUIDE 469
TABLE 756 AIR LIQUIDE: BUSINESS OVERVIEW 469
FIGURE 44 AIR LIQUIDE: COMPANY SNAPSHOT (2022) 470
12.1.12 DOW 473
TABLE 757 DOW: BUSINESS OVERVIEW 473
FIGURE 45 DOW: COMPANY SNAPSHOT (2022) 473
12.1.13 LUBRIZOL CORPORATION (BERKSHIRE HATHAWAY) 475
TABLE 758 LUBRIZOL CORPORATION: BUSINESS OVERVIEW 475
12.1.14 COLORCON 478
TABLE 759 COLORCON: BUSINESS OVERVIEW 478
12.1.15 DFE PHARMA 481
TABLE 760 DFE PHARMA: BUSINESS OVERVIEW 481
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 485
12.2.1 INNOPHOS 485
12.2.2 J. RETTENMAIER & SÖHNE GMBH + CO KG 486
12.2.3 ACTYLIS 487
12.2.4 MEGGLE GMBH & CO. KG 490
12.2.5 FUJI CHEMICAL INDUSTRIES CO., LTD. 491
12.2.6 COREL PHARMA CHEM 491
12.2.7 BIOGRUND GMBH 492
12.2.8 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD. 492
12.2.9 R.T. VANDERBILT HOLDING COMPANY, INC. 494
12.2.10 BENEO 495
 
13 APPENDIX 496
13.1 DISCUSSION GUIDE 496
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 500
13.3 CUSTOMIZATION OPTIONS 502
13.4 RELATED REPORTS 502
13.5 AUTHOR DETAILS 503
보고서 이미지

※본 조사보고서 [세계의 의약품 첨가제 시장 (~2028년) : 제품별 (유기 (유기 화학, 탄수 화물), 무기 (탄산 칼슘)), 기능별 (충전제, 결합제, 윤활제, 희석제), 제형별 (경구제, 비경구제), 용도별 (안정제)] (코드 : PH3047-24) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 의약품 첨가제 시장 (~2028년) : 제품별 (유기 (유기 화학, 탄수 화물), 무기 (탄산 칼슘)), 기능별 (충전제, 결합제, 윤활제, 희석제), 제형별 (경구제, 비경구제), 용도별 (안정제)] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 세포 및 유전자 치료 제조 서비스 시장 (~2027년) : 종류별 (동종, 자가, 바이러스 벡터, 비바이러스 벡터), 질환별 (종양, 정형외과, 안과), 용도별 (임상, 상업), 최종 용도별 (제약, 바이오테크놀로지)
    BT7944-23 / MarketsandMarkets / 2023년 1월 / MarketsandMarkets사는 세계의 세포 및 유전자 치료 제조 서비스 시장 규모가 2022년 51억 달러에서 2027년 115억 달러에 이르며, 예측 기간 동안 연평균 17.5%로 성장할 것으로 추정하고 있습니다. 본 조사 보고서는 세계의...“The global cell & gene therapy manufacturing services market size is projected to reach USD 11.5 billion by 2027 from USD 5.1 billion in 2022, at a CAGR of 17.5% during the forecast period.” Growth in this market can be attributed to rapidly increasing private equity and capital investment in...
  • 세계의 체외진단 (IVD) 시장 (~2027년)
    MD3609-23 / MarketsandMarkets / 2023년 1월 / 마켓츠앤마켓츠 (MarketsandMarkets)에 따르면 세계의 체외진단 (IVD) 시장 규모가 2022년 1,158억 달러에서 2027년 1, 447억 달러까지 연평균 4.6% 성장할 것으로 추정하고 있습니다. 본 조사 자료는 세계의 체외진단 (IVD) 시장에 대해 조사...“The in vitro market is projected to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%.” The growing adoption of point-of-care devices and rapid tests for early disease diagnosis, and the rising government initiatives & funding for preventive cure with early diagnosis...
  • 세계의 마이크로바이옴 진단 시장 (~2028년) : 제품별 (키트 및 시약, 기기), 기술별 (16srRNA 시퀀싱, 샷건 메타게노믹스, 메타 전사체학), 샘플별 (대변, 타액, 피부), 용도별 (소화관, 대사 장애)
    MD8949-24 / MarketsandMarkets / 2024년 2월 / "세계의 마이크로바이옴 진단 시장은 2023년 약 1억 4600만 달러로 평가되며, 예측 기간 동안 15.5%의 CAGR로 성장하여 2028년까지 3억 달러에 달할 것으로 예상됩니다." 시장 성장의 원동력은 마이크로바이옴 진단에 대한 인식 개선,...1 서론 2 조사 방법 3 개요 4 프리미엄 인사이트 5 시장 개요 6 세계의 마이크로바이옴 진단 시장 규모 : 제품별 7 세계의 마이크로바이옴 진단 시장 규모 : 기술별 8 세계의 마이크로바이옴 진단 시장 규모 : 샘플별 9 세계의 마이크로바이옴 진단 시장 규모 : 용도별 10 세계의 마이크로바이옴 진단 시장...
  • 세계의 전기 치료/생체 전기 의료 시장 (~2029년) : 제품별 (심장 박동기, ICD, 인공 와우, 신경 조절 (뇌심부자극)), 유형별 (이식형, 비침습형), 용도별 (부정맥, 심부전, 간질)
    MD4358-24 / MarketsandMarkets / 2024년 3월 / "세계의 전기 치료/생체 전기 의료 시장은 예측 기간 동안 연평균 7.0%의 성장률로 2024년 23.9억 달러에서 2029년 33.6억 달러로 성장할 것으로 예상됩니다." 이러한 성장은 주로 심장 리듬 관리(CRM) 기기에 대한 연구...1 서론 2 조사 방법 3 개요 4 프리미엄 인사이트 5 시장 개요 6 세계의 전기 치료/생체 전기 의료 시장 규모 : 제품별 7 세계의 전기 치료/생체 전기 의료 시장 규모 : 유형별 8 세계의 전기 치료/생체 전기 의료 시장 규모 : 응용 분야별 9 세계의 전기 치료/생체 전기 의료...
  • 세계의 약물 스크리닝 시장 (~2029년) : 제품별 (신속 검사 (소변, 구강), 분석 (호흡 검출기, 면역 측정, 크로마토그래피)), 샘플별 (소변, 호흡, 모발), 약물별 (알코올, 대마초, 오피오이드), 최종 용도별 (직장, 병원, 법집행 기관)
    MD3239 / MarketsandMarkets / 2024년 5월 / ...“세계의 약물 스크리닝 시장은 2024년 91억 달러에서 2029년 195억 달러로 16.6%의 연평균 성장률을 기록할 것으로 예상됩니다.”약물 및 알코올 검사를 의무화하는 엄격한 법률 시행, 약물 및 알코올 소비 증가, 약물 스크리닝 제품 및 서비스에 대한 규제 승인 증가와 같은 요인이 그 원인입니다. 그러나 이슬람 국가에서의 음주 금지와 특정 국가에서의 직장 내...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!